The gut microbiota have long been recognized to play a key role in human health and
disease. Currently, several lines of evidence from preclinical to clinical research have …

The immune-related adverse events associated with treatment with immune checkpoint
inhibitors result in significant morbidity for patients as well as considerable cost to the health …

Background Immune checkpoint inhibitors (ICI) either alone or in combination with
chemotherapy have expanded our choice of agents for the palliative treatment of non-small …

Importance Immune-related adverse events (irAEs) secondary to immune checkpoint
inhibitor (ICI) therapy reportedly improve overall survival (OS) in patients with non–small cell …

The timing of immune-related adverse events (irAE) associated with immune checkpoint
inhibitors (ICI) is highly variable. Although the development of irAE has been associated with …

Tumor immunity consists of various types of cells, which serve an important role in antitumor
therapy. The gastrointestinal tract is colonized by trillions of microorganisms, which form the …

Simple Summary This study examined the real-world experience and occurrence of immune-
related adverse events (irAEs) under cancer checkpoint immunotherapy, and the …

Abstract Background Immune checkpoint inhibitors (ICIs) are standard of care in advanced
non-small cell lung cancer (NSCLC), however their status in patients with poor performance …

Background Immune-related adverse events (irAEs) from immune checkpoint inhibitors
(ICIs) are sometimes associated with autoantibodies, but we do not know how frequently or …

Background Immune-related adverse events (irAEs) have been reported to be associated
with the efficacy of immunotherapy. Herein, we conducted a meta-analysis to demonstrate …